ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health behaviors"

  • Abstract Number: 0084 • ACR Convergence 2022

    Facilitators and Barriers of Vaccine Uptake in Patients with Chronic Inflammatory Rheumatic Disease: A Scoping Review

    Silke Neusser1, Anja Neumann1, Christian Speckemeier1, Pauline zur NIeden1, Sarah Schlierenkamp1, Anke Walendzik1, Ute Karbach2, Ioana Andreica3, Kristina Vaupel4, Xenofon Baraliakos5 and Uta Kiltz4, 1Essener Forschungsinstitut für Medizinmanagement, Essen, Germany, 2Institute of Medical Sociology, Health Services Research and Rehabilitation Science (IMVR), Cologne, Germany, 3Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Patients with chronic inflammatory rheumatic diseases (CIRD) remain underrepresented in receiving vaccinations despite being disproportionately affected by infectious complications. The aim of our study…
  • Abstract Number: 2190 • ACR Convergence 2022

    Characterizing Compensatory Cognitive Strategy Use in People with Systemic Sclerosis

    Yen Chen1, Alain Lescoat2, Dinesh Khanna3 and Susan Murphy4, 1University of Michigan, Ann Arbor, MI, 2CHU Rennes - University Rennes 1, Rennes, France, 3Division of Rheumatology, Department of Internal Medicine, Scleroderma Program, University of Michigan, Ann Arbor, MI, 4University of Michigan, Grosse Ile, MI

    Background/Purpose: Individuals with systemic sclerosis (SSc) report cognitive problems that worsen symptoms and daily activity performance. Compensatory cognitive strategies (CCS) are commonly taught to help…
  • Abstract Number: 0115 • ACR Convergence 2022

    Facilitators of Immunosuppressive Medication Adherence in Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers and Clinic Staff

    Shannon Herndon1, Amy Corneli2, Carrie Dombeck3, Teresa Swezey3, Megan Clowse3, Jennifer Rogers4, Lisa Criscione-Schreiber2, Rebecca Sadun3, Jayanth Doss3, Amanda Eudy5, Hayden Bosworth2 and Kai Sun3, 1Duke University Hospital, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3Duke University, Durham, NC, 4Duke, Durham, NC, 5Duke University, Raleigh, NC

    Background/Purpose: SLE disproportionately affects patients of color. Medication nonadherence is more common among patients of color with SLE and is associated with worse health outcomes.…
  • Abstract Number: 2247 • ACR Convergence 2022

    Priority Research Topics for Vaccine Uptake Among Adults with Autoimmune Conditions

    Shilpa Venkatachalam1, William Benjamin Nowell2, Shubhasree Banerjee3, Kelly Gavigan4, Laura Stradford2, Jennifer Gordon5, Lisa Emerich6, Hope Sullivan7, Ashira Blazer8, Brittany Banbury9, Vandana Dronadula1, Kimberly Weaver10, Angela Degrassi4, Peter Merkel3, Robert McBurney11, Mike Kappelman10, Jeffrey Curtis12 and Michael George3, 1Global Healthy Living Foundation, New York, NY, 2Global Healthy Living Foundation, Nyack, NY, 3University of Pennsylvania, Philadelphia, PA, 4Global Healthy Living Foundation, Upper Nyack, NY, 5Vasculitis Foundation, Philadelphia, 6iConquerMS, Waltham, MA, 7Inflammatory Bowel Disease (IBD) Partners, Chapel Hill, NC, 8Hospital for Special Surgery, New York, NY, 9NYU Langone, Fort Lee, NJ, 10School of Medicine, University of North Carolina (UNC), Chapel Hill, NC, 11Accelerated Cure Project for Multiple Sclerosis, Waltham, MA, 12University of Alabama at Birmingham, Hoover, AL

    Background/Purpose: Compared to the general population, adults living with autoimmune disease are at nearly twice the risk of vaccine-preventable infections, making this a high priority…
  • Abstract Number: 0116 • ACR Convergence 2022

    Racial Differences in Medication Beliefs and Barriers to Taking Medications Among Patients with SLE

    Emilio Guzman Cisneros1, Shannon Herndon1, Theresa Coles2, Corrine Voils3, Megan Clowse4, Rebecca Sadun4, Jennifer Rogers5, Lisa Criscione-Schreiber2, Jayanth Doss4, Amanda Eudy6 and Kai Sun4, 1Duke University Hospital, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Duke University, Durham, NC, 5Duke, Durham, NC, 6Duke University, Raleigh, NC

    Background/Purpose: Medication adherence is critical for SLE management and can be influenced by patients' barriers and beliefs about treatment. Patients of color with SLE have…
  • Abstract Number: PP05 • ACR Convergence 2022

    From Practical Tips to Heartfelt Encouragement: How Social Media Can Improve Quality of Life with Rheumatic Disease

    Cheryl Crow1 and Zoe Rothblatt2, 1Arthritis Life, Bellevue, WA, 2Global Healthy Living Foundation, New York, NY

    Background/Purpose: Living with different autoimmune rheumatic diseases, we (Cheryl and Zoe) share similar struggles with disease management, and successes in learning new ways to use…
  • Abstract Number: 0182 • ACR Convergence 2022

    Newly Diagnosed with Inflammatory Arthritis. Development of a Complex Self-management Intervention

    Luise Lindgren1, Tanja Thomsen2, Mette Aadahl3, Sara Kristensen4, Bente Esbensen5, Annette de Thurah6 and Merete L Hetland5, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 2Rigshospitalet, Glostrup, Center for Rheumatology and Spine Diseases. COPECARE, Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Glostrup, Denmark, 3Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Denmark.Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, Frederiksberg, Denmark, 4Patient research partner, Frederiksberg, Denmark, 5Rigshospitalet, Glostrup, Denmark, 6Department of Rheumatology, Aarhus University Hospital, Denmark. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

    Background/Purpose: Patients newly diagnosed with inflammatory arthritis (IA) request regular consultations and support from health professionals (HPRs) in rheumatology to manage physiological, emotional, and social…
  • Abstract Number: 1287 • ACR Convergence 2021

    Association of Limited Health Literacy with Patient-Provider Communication in Systemic Lupus Erythematosus

    Ann Barr1, Catherine Howe2, Jennifer Rogers1, Jayanth Doss1, Rebecca Sadun1, Lisa Criscione-Schreiber3, Megan Clowse4, Kai Sun3 and Mithu Maheswaranathan3, 1Duke University, Durham, NC, 2Duke University Hospital, Durham, NC, 3Duke University School of Medicine, Durham, NC, 4Duke University, Chapel Hill, NC

    Background/Purpose: Low health literacy is common among US adults, including patients with SLE, and is associated with higher disease activity and worse patient-reported outcomes. The…
  • Abstract Number: 1371 • ACR Convergence 2021

    Symptom Management in Systemic Sclerosis: A Pilot Study of a Web-based Intervention Using Peer-Health Coaches

    Susan Murphy1, Yen Chen2, Mary Alore2, Sheri Hicks2 and Dinesh Khanna2, 1University of Michigan, Grosse Ile, MI, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: People with systemic sclerosis (SSc) have a high burden of chronic symptoms that have dramatic effects on function and quality of life. Fatigue, along…
  • Abstract Number: 0031 • ACR Convergence 2021

    A New Pharmacostatistical Model to Assess MTX-adherence in RA Patients

    Marion Geoffroy1, Claire Gozalo2, Loic Pauvele2, Elise Abboud2, Zoubir Djerada3 and Jean hugues Salmon4, 1CHU Reims, France, REIMS, France, 2CHU Reims, Reims, France, 3CHU Riems, Reims, France, 4Rheumatology, CHU Maison blanche, Reims, Reims, France

    Background/Purpose: Methotrexate (MTX) is the first-line therapy for rheumatoid arthritis (RA). While therapeutic adherence is essential to the successful management of the patient, an estimated…
  • Abstract Number: 1599 • ACR Convergence 2021

    Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Rheumatic Conditions: A Qualitative Analysis of Perceived Risk and Decision Making

    Courtney Wells1, Guadalupe Torres2, William Nowell3, Shilpa Venkatachalam3, Laura Stradford4, Kelly Gavigan3, Barbara Boyd-Floering5, Maria I. Danila6 and Kristine Carandang7, 1University of Wisconsin-River Falls, White Bear Lake, MN, 2Patient Partner, Brooklyn Center, MN, 3Global Healthy Living Foundation, Upper Nyack, NY, 4Global Healthy Living Foundation, Nyack, NY, 5Whelton Virshup CreakyJoints Arthritis Clinic/ Global Healthy Living Foundation, Lake Worth, FL, 6University of Alabama at Birmingham, Birmingham, AL, 7Independent, San Diego, CA

    Background/Purpose: The purpose of this qualitative study was to understand the concerns, behaviors, and experiences of adults with autoimmune rheumatic conditions, and to evaluate the…
  • Abstract Number: 0098 • ACR Convergence 2021

    Patients with Chronic Inflammatory Rheumatic Diseases Report a Lower Frequency of Infections Than Controls and They Protect Themselves Well Against SARS-CoV-2 Transmission

    Iulia Roman, Ioana Andreica, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: The SARS-CoV-2 pandemic has affected life in most countries around the world for more than a year now. It is not entirely clear if…
  • Abstract Number: 1608 • ACR Convergence 2021

    Sources of Information About SARS-CoV-2 Used by Patients with Chronic Inflammatory Rheumatic Diseases (CIRD)

    Ioana Andreica, Iulia Roman, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Patients with chronic inflammatory rheumatic diseases (CIRD) may be at increased risk of Corona Virus Disease 2019 (COVID-19).1 The quality of information obtained plays…
  • Abstract Number: 0122 • ACR Convergence 2021

    Clinical Impact of a Digital Behavioral Therapy for Fibromyalgia Management: A Randomized Controlled Trial

    Stephanie Catella1, Michael Gendreau2, Nicolette Vega1, Allison Kraus1, Michael Rosenbluth1, Sherry Soefje3, Shishuka Malhotra4 and Lesley Arnold5, 1Swing Therapeutics, San Francisco, CA, 2Gendreau Consulting, LLC, Poway, CA, 3Excell Research, Oceanside, CA, 4Neuro-Behavioral Clinical Research, North Canton, OH, 5University of Cincinnati, Cincinnati, OH

    Background/Purpose: Recommendations for fibromyalgia management include both pharmacologic and nonpharmacologic treatments. Cognitive behavioral therapy (CBT) has demonstrated level 1A evidence for fibromyalgia management, though access…
  • Abstract Number: 1609 • ACR Convergence 2021

    SARS-CoV-2 Vaccination Willingness and Its Predictors in Patients with Chronic Inflammatory Rheumatic Diseases (CIRD)

    Iulia Roman, Ioana Andreica, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Whether patients with chronic rheumatic diseases (CIRD) are at increased risk of developing severe COVID 19 infections is not entirely clear. However, some DMARDs…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology